We are live on ! Find out more
Skandinaviska Enskilda Banken (SEB)

Skandinaviska Enskilda Banken (SEB) Portfolio holdings

AUM $2.66B
1-Year Est. Return 26.2%
This Fund
S&P 500
This Quarter Est. Return
-0.81%
1 Year Est. Return
+26.2%
3 Year Est. Return
+111.17%
5 Year Est. Return
+154.66%
10 Year Est. Return
+614.64%
AUM
$10.4B
AUM Growth
-$1.25B
Cap. Flow
-$1.2B
Cap. Flow %
-11.58%
Top 10 Hldgs %
26.01%
Holding
742
New
32
Increased
158
Reduced
480
Closed
40

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$149M
2
KMB icon
Kimberly-Clark
KMB
+$142M
3
CA
CA, Inc.
CA
+$110M
4
T icon
AT&T
T
+$76.8M
5
CM icon
Canadian Imperial Bank of Commerce
CM
+$64.9M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$289M
2
BMY icon
Bristol-Myers Squibb
BMY
+$91.3M
3
FL
Foot Locker
FL
+$89.4M
4
INTC icon
Intel
INTC
+$89.2M
5
JNJ icon
Johnson & Johnson
JNJ
+$78.9M

Sector Composition

Rank Sector Weight
1 Technology 19.15%
2 Healthcare 18.3%
3 Financials 15.97%
4 Consumer Discretionary 14.12%
5 Consumer Staples 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIM
126
Chimera Investment
CIM
$991M
$13.4M 0.13%
256,300
IDXX icon
127
Idexx Laboratories
IDXX
$45B
$12.9M 0.12%
67,234
-1,995
-3% -$368K
ABT icon
128
Abbott
ABT
$192B
$12.2M 0.12%
204,145
-113,712
-36% -$6.85M
BMY icon
129
Bristol-Myers Squibb
BMY
$130B
$12.2M 0.12%
193,034
-1,419,631
-88% -$91.3M
ALXN
130
DELISTED
Alexion Pharmaceuticals
ALXN
$12.2M 0.12%
109,440
-28,678
-21% -$3.43M
UNP icon
131
Union Pacific
UNP
$174B
$12.2M 0.12%
90,601
-52,807
-37% -$7.11M
VYX icon
132
NCR Voyix
VYX
$1.12B
$11.2M 0.11%
576,710
+1,956
+0.3% +$41.2K
VRTX icon
133
Vertex Pharmaceuticals
VRTX
$133B
$11.1M 0.11%
68,200
-10,331
-13% -$1.69M
ARCC icon
134
Ares Capital
ARCC
$14.3B
$11.1M 0.11%
699,206
-55,478
-7% -$879K
BRK.A icon
135
Berkshire Hathaway Class A
BRK.A
$1.09T
$11.1M 0.11%
37
-3
-8% -$925K
RNET
136
DELISTED
RigNet, Inc.
RNET
$11M 0.11%
808,089
KKR icon
137
KKR & Co
KKR
$99.5B
$10.9M 0.11%
537,758
-66,437
-11% -$1.48M
QCOM icon
138
Qualcomm
QCOM
$171B
$10.8M 0.1%
195,150
-74,923
-28% -$4.77M
NKE icon
139
Nike
NKE
$60.1B
$10.8M 0.1%
161,972
-78,536
-33% -$5.18M
RY icon
140
Royal Bank of Canada
RY
$297B
$10.6M 0.1%
106,785
-8,457
-7% -$687K
CG icon
141
Carlyle Group
CG
$17.2B
$10.6M 0.1%
495,479
-63,000
-11% -$1.48M
GS icon
142
Goldman Sachs
GS
$302B
$10.5M 0.1%
41,883
-22,572
-35% -$5.88M
FCRD
143
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$10.5M 0.1%
1,351,629
-30,000
-2% -$256K
BDX icon
144
Becton Dickinson
BDX
$50B
$10.4M 0.1%
49,087
+4,242
+9% +$929K
CAT icon
145
Caterpillar
CAT
$393B
$10M 0.1%
67,879
-36,113
-35% -$5.7M
TMO icon
146
Thermo Fisher Scientific
TMO
$223B
$10M 0.1%
48,456
-23,114
-32% -$4.85M
TUP
147
DELISTED
Tupperware Brands Corporation
TUP
$9.99M 0.1%
206,400
-444,500
-68% -$24.3M
BX icon
148
Blackstone
BX
$110B
$9.92M 0.1%
310,625
-24,134
-7% -$823K
COST icon
149
Costco
COST
$421B
$9.82M 0.09%
52,105
-28,061
-35% -$5.29M
SLB icon
150
SLB Ltd
SLB
$78.1B
$9.62M 0.09%
148,529
-127,957
-46% -$8.94M

Similar funds

Skandinaviska Enskilda Banken (SEB)'s Q1 2018 Portfolio in Review

As of Q1 2018, Skandinaviska Enskilda Banken (SEB) held 742 positions worth $10.4B, down 11% from $11.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Skandinaviska Enskilda Banken (SEB) withdrew a net $1.2B in Q1 2018, closing 40 positions and reducing 480 holdings. Its most notable exit was Global Cord Blood Corporation, an estimated $29.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Skandinaviska Enskilda Banken (SEB) opened a new position in Xerox worth $15.9M.

  • Skandinaviska Enskilda Banken (SEB)'s largest Q1 2018 buy was Xerox: 550,760 shares worth $15.9M.
  • Skandinaviska Enskilda Banken (SEB) added most to Pfizer in Q1 2018, an estimated $149M increase.
  • Skandinaviska Enskilda Banken (SEB)'s biggest Q1 2018 reduction was Gilead Sciences, cutting an estimated $289M.
  • Skandinaviska Enskilda Banken (SEB) fully exited Global Cord Blood Corporation in Q1 2018, selling an estimated $29.2M.
  • Skandinaviska Enskilda Banken (SEB)'s ten largest holdings make up 26% of its $10.4B portfolio in Q1 2018.
  • Skandinaviska Enskilda Banken (SEB) opened 32 new positions and closed 40 in Q1 2018.
  • Skandinaviska Enskilda Banken (SEB)'s portfolio value fell 11% quarter-over-quarter to $10.4B.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2018, filed 30 Apr 2018.